FOLH1 and prostate cancer: Moving to in vivo studies, this specificity and efficacy were further confirmed in a zebrafish PCa xenograft model, where targeted LNPs showed enhanced accumulation and transfection in PSMA+ prostate cancer cells that had metastasized to the caudal region (Figure 4D,E).